• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BXN
Click for more information
16.7% 1.5¢

BIOXYNE LIMITED - Announcements

Market Cap $26.60M  ! watchlist Created with Sketch. Add to my watchlist

Bioxyne Limited is an Australia-based international consumer health and pharmaceutical... Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BXN Appendix 4D and Half Year AccountsPRICE SENSITIVE20/02/19
BXN Appendix 4C - quarterlyPRICE SENSITIVE30/01/19
BXN Final Director's Interest Notice21/01/19
BXN Director Resignation17/01/19
BXN Change of Directors Interest Notice X 521/12/18
BXN Appendix 3B21/12/18
BXN Results of Meeting29/11/18
BXN Quarterly Activities ReportPRICE SENSITIVE29/10/18
BXN Appendix 4C - quarterlyPRICE SENSITIVE29/10/18
BXN Notice of Annual General Meeting/Proxy Form25/10/18
BXN Change of Director's Interest Notice16/10/18
BXN Annual Report to shareholders28/09/18
BXN Appendix 4G and Corporate Governance Statement28/09/18
BXN Bioxyne Expands to Indonesia with AcquisitionPRICE SENSITIVE25/09/18
BXN Preliminary Final ReportPRICE SENSITIVE31/08/18
BXN Change of Director's Interest Notice06/08/18
BXN Quarterly Activities and Quarterly Cash Flow ReportPRICE SENSITIVE27/07/18 download Created with Sketch. 789.88KB
BXN Change of Director's Interest Notice16/07/18 download Created with Sketch. 301.85KB
BXN Change of Director's Interest Notice10/07/18 download Created with Sketch. 301.93KB
BXN Change of Director's Interest Notice22/06/18 download Created with Sketch. 301.53KB
BXN Change of Director's Interest Notice20/06/18 download Created with Sketch. 301.23KB
BXN Bioxyne to Distribute GRAYNS Starch Reducing Rice CookerPRICE SENSITIVE12/06/18 download Created with Sketch. 712.23KB
BXN Clarification to Announcement21/05/18
BXN Expands to Thailand, Philippines, Myanmar, Cambodia,PRICE SENSITIVE21/05/18
BXN Initial Director's Interest Notice04/05/18
BXN Appointment of Non-Executive Director01/05/18
BXN Securities Trading Policy - Updated30/04/18
BXN Quarterly Activities and Quarterly Cash Flow ReportsPRICE SENSITIVE27/04/18
BXN Investor Update19/03/18
BXN Response to ASX Query LetterPRICE SENSITIVE01/03/18
BXN Appendix 4D and Interim Financial ReportPRICE SENSITIVE28/02/18
BXN Unique NZ Colostrum Honey Dairy Product for China and S.E.APRICE SENSITIVE26/02/18
BXN Final Director's Interest Notice16/02/18
BXN Director Resignation15/02/18
BXN Appendix 3B Corrected15/02/18
BXN Quarterly Activities and Quarterly Cash Flow Report Dec 17PRICE SENSITIVE30/01/18
BXN Change of Director's Interest Notice17/01/18
BXN Additional New Products Launched for Direct SalesPRICE SENSITIVE16/01/18
BXN Appendix 3B19/12/17
BXN Third Party Claim14/12/17
BXN Appendix 3B11/12/17
BXN Change of Directors Interest X 311/12/17
BXN Positive Bioxyne Gut Health Clinical Trial ResultsPRICE SENSITIVE11/12/17
BXN Change of Directors Interest Notice X 207/12/17
BXN Bioxyne Launches NZ Dairy Formula Product in South East AsiaPRICE SENSITIVE07/12/17
BXN Appendix 3B Amended07/12/17
BXN Appendix 3B05/12/17
BXN Change of Share Registry01/12/17
BXN Results of Meeting28/11/17
BXN Letter to Optionholders15/11/17
BXN Change of Director's Interest Notice01/11/17
BXN Appendix 3B27/10/17
BXN Notice of Annual General Meeting/Proxy Form26/10/17
BXN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE25/10/17
BXN Malaysian Direct Selling Licence to Propel Bioxyne into MLMPRICE SENSITIVE25/10/17
BXN Appendix 3B17/10/17
BXN Response to ASX Price Query LetterPRICE SENSITIVE16/10/17
BXN Appendix 3B12/10/17
BXN Appendix 4G25/09/17
BXN Annual Report to shareholders25/09/17
BXN Appendix 3B22/09/17
BXN BXN Extends Product Range, New Website, Marketing Campaign18/09/17
BXN Appendix 4E Preliminary Final ReportPRICE SENSITIVE31/08/17
BXN Change in substantial holding08/08/17
BXN Directors Change in Interest X 304/08/17
BXN Appendix 3B04/08/17
BXN Results of Meeting03/08/17
BXN Quarterly Activities Appendix 4CPRICE SENSITIVE31/07/17
BXN Appendix 3B11/07/17
BXN Notice of General Meeting/Proxy Form03/07/17
BXN Change in substantial holding26/06/17
BXN Directors Initial Interest Notice X 213/06/17
BXN Becoming a substantial holder13/06/17
BXN Appointment of Directors13/06/17
BXN Share Sale Facility for Unmarketable Parcels01/06/17
BXN Directors Change in Interest X 231/05/17
BXN Appendix 3B30/05/17
BXN Rights Issue - Notification of ShortfallPRICE SENSITIVE26/05/17
BXN Appendix 3B08/05/17
BXN Rights Issue - Letter to Ineligible Shareholders04/05/17
BXN Letter to Shareholders - Rights Issue03/05/17
BXN Prospectus - Rights IssuePRICE SENSITIVE03/05/17
BXN Quarterly Activities and Cash Flow Report March 2017PRICE SENSITIVE27/04/17
BXN Cleansing Statement21/04/17
BXN Appendix 3B21/04/17
BXN Letter to Optionholders19/04/17
BXN Listing Rule 7.1A Information19/04/17
BXN Appendix 3B19/04/17
BXN Acquires NZ Product Company for Direct Sales Asia PacificPRICE SENSITIVE19/04/17
BXN Trading HaltPRICE SENSITIVE13/04/17
BXN Appendix 4D and Half Year ReportPRICE SENSITIVE27/02/17
BXN Bioxyne to Access Chinese Market for Online Sales via JD.comPRICE SENSITIVE21/02/17
BXN Response to ASX Appendix 3Y Letter08/02/17
BXN Issue of Options, Appendix 3B, Appendix 3Y X 203/02/17
BXN Quarterly Activities and Cash Flow Report Dec 2016PRICE SENSITIVE25/01/17
BXN Change of Director's Interest Notice13/01/17
BXN Details of Company Address29/12/16
BXN Results of Meeting24/11/16
BXN AGM Notice - Amendment to Resolutions23/11/16
BXN AGM - Amendment to Resolutions21/11/16
BXN Appendix 4D and Half Year Accounts
20/02/19PRICE SENSITIVE
BXN Appendix 4C - quarterly
30/01/19PRICE SENSITIVE
BXN Final Director's Interest Notice
21/01/19
BXN Director Resignation
17/01/19
BXN Change of Directors Interest Notice X 5
21/12/18
BXN Appendix 3B
21/12/18
BXN Results of Meeting
29/11/18
BXN Quarterly Activities Report
29/10/18PRICE SENSITIVE
BXN Appendix 4C - quarterly
29/10/18PRICE SENSITIVE
BXN Notice of Annual General Meeting/Proxy Form
25/10/18
BXN Change of Director's Interest Notice
16/10/18
BXN Annual Report to shareholders
28/09/18
BXN Appendix 4G and Corporate Governance Statement
28/09/18
BXN Bioxyne Expands to Indonesia with Acquisition
25/09/18PRICE SENSITIVE
BXN Preliminary Final Report
31/08/18PRICE SENSITIVE
BXN Change of Director's Interest Notice
06/08/18
BXN Quarterly Activities and Quarterly Cash Flow Report
27/07/18PRICE SENSITIVE download Created with Sketch. 789.88KB
BXN Change of Director's Interest Notice
16/07/18 download Created with Sketch. 301.85KB
BXN Change of Director's Interest Notice
10/07/18 download Created with Sketch. 301.93KB
BXN Change of Director's Interest Notice
22/06/18 download Created with Sketch. 301.53KB
BXN Change of Director's Interest Notice
20/06/18 download Created with Sketch. 301.23KB
BXN Bioxyne to Distribute GRAYNS Starch Reducing Rice Cooker
12/06/18PRICE SENSITIVE download Created with Sketch. 712.23KB
BXN Clarification to Announcement
21/05/18
BXN Expands to Thailand, Philippines, Myanmar, Cambodia,
21/05/18PRICE SENSITIVE
BXN Initial Director's Interest Notice
04/05/18
BXN Appointment of Non-Executive Director
01/05/18
BXN Securities Trading Policy - Updated
30/04/18
BXN Quarterly Activities and Quarterly Cash Flow Reports
27/04/18PRICE SENSITIVE
BXN Investor Update
19/03/18
BXN Response to ASX Query Letter
01/03/18PRICE SENSITIVE
BXN Appendix 4D and Interim Financial Report
28/02/18PRICE SENSITIVE
BXN Unique NZ Colostrum Honey Dairy Product for China and S.E.A
26/02/18PRICE SENSITIVE
BXN Final Director's Interest Notice
16/02/18
BXN Director Resignation
15/02/18
BXN Appendix 3B Corrected
15/02/18
BXN Quarterly Activities and Quarterly Cash Flow Report Dec 17
30/01/18PRICE SENSITIVE
BXN Change of Director's Interest Notice
17/01/18
BXN Additional New Products Launched for Direct Sales
16/01/18PRICE SENSITIVE
BXN Appendix 3B
19/12/17
BXN Third Party Claim
14/12/17
BXN Appendix 3B
11/12/17
BXN Change of Directors Interest X 3
11/12/17
BXN Positive Bioxyne Gut Health Clinical Trial Results
11/12/17PRICE SENSITIVE
BXN Change of Directors Interest Notice X 2
07/12/17
BXN Bioxyne Launches NZ Dairy Formula Product in South East Asia
07/12/17PRICE SENSITIVE
BXN Appendix 3B Amended
07/12/17
BXN Appendix 3B
05/12/17
BXN Change of Share Registry
01/12/17
BXN Results of Meeting
28/11/17
BXN Letter to Optionholders
15/11/17
BXN Change of Director's Interest Notice
01/11/17
BXN Appendix 3B
27/10/17
BXN Notice of Annual General Meeting/Proxy Form
26/10/17
BXN Quarterly Activities Report and Appendix 4C
25/10/17PRICE SENSITIVE
BXN Malaysian Direct Selling Licence to Propel Bioxyne into MLM
25/10/17PRICE SENSITIVE
BXN Appendix 3B
17/10/17
BXN Response to ASX Price Query Letter
16/10/17PRICE SENSITIVE
BXN Appendix 3B
12/10/17
BXN Appendix 4G
25/09/17
BXN Annual Report to shareholders
25/09/17
BXN Appendix 3B
22/09/17
BXN BXN Extends Product Range, New Website, Marketing Campaign
18/09/17
BXN Appendix 4E Preliminary Final Report
31/08/17PRICE SENSITIVE
BXN Change in substantial holding
08/08/17
BXN Directors Change in Interest X 3
04/08/17
BXN Appendix 3B
04/08/17
BXN Results of Meeting
03/08/17
BXN Quarterly Activities Appendix 4C
31/07/17PRICE SENSITIVE
BXN Appendix 3B
11/07/17
BXN Notice of General Meeting/Proxy Form
03/07/17
BXN Change in substantial holding
26/06/17
BXN Directors Initial Interest Notice X 2
13/06/17
BXN Becoming a substantial holder
13/06/17
BXN Appointment of Directors
13/06/17
BXN Share Sale Facility for Unmarketable Parcels
01/06/17
BXN Directors Change in Interest X 2
31/05/17
BXN Appendix 3B
30/05/17
BXN Rights Issue - Notification of Shortfall
26/05/17PRICE SENSITIVE
BXN Appendix 3B
08/05/17
BXN Rights Issue - Letter to Ineligible Shareholders
04/05/17
BXN Letter to Shareholders - Rights Issue
03/05/17
BXN Prospectus - Rights Issue
03/05/17PRICE SENSITIVE
BXN Quarterly Activities and Cash Flow Report March 2017
27/04/17PRICE SENSITIVE
BXN Cleansing Statement
21/04/17
BXN Appendix 3B
21/04/17
BXN Letter to Optionholders
19/04/17
BXN Listing Rule 7.1A Information
19/04/17
BXN Appendix 3B
19/04/17
BXN Acquires NZ Product Company for Direct Sales Asia Pacific
19/04/17PRICE SENSITIVE
BXN Trading Halt
13/04/17PRICE SENSITIVE
BXN Appendix 4D and Half Year Report
27/02/17PRICE SENSITIVE
BXN Bioxyne to Access Chinese Market for Online Sales via JD.com
21/02/17PRICE SENSITIVE
BXN Response to ASX Appendix 3Y Letter
08/02/17
BXN Issue of Options, Appendix 3B, Appendix 3Y X 2
03/02/17
BXN Quarterly Activities and Cash Flow Report Dec 2016
25/01/17PRICE SENSITIVE
BXN Change of Director's Interest Notice
13/01/17
BXN Details of Company Address
29/12/16
BXN Results of Meeting
24/11/16
BXN AGM Notice - Amendment to Resolutions
23/11/16
BXN AGM - Amendment to Resolutions
21/11/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
1.5¢ 		Change
-0.003(16.7%) 		Mkt cap ! $26.60M
Open High Low Value Volume
1.9¢ 2.1¢ 1.5¢ $85.90K 4.888M

Buyers (Bids)

No. Vol. Price($)
7 1400075 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 67981 1
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
Last
1.6¢ 		  Change
-0.003 ( 11.1 %)
Open High Low Volume
2.0¢ 2.1¢ 1.5¢ 3408417
Last updated 15.57pm 29/11/2024 ?
BXN (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
Resolute shares bounce back as second payment made to Mali government to secure workers' release Resolute Mining Ltd has told investors that a second payment has been made to the Mali government following the detention of three employees
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia New Zealand’s Reserve Bank has taken a bold step, slashing rates by 50 basis points to 4.25% @ its third cut in just four months. Meanwhile, the Reserve Bank of Australia holds firm at 4.35%, its highest rate in over a decade.This stark policy divergence highlights contrasting glo...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.